AIM: To determine the genotypes in Mexican hepatitis B virus (HBV) isolates and characterize their precore and core promoter mutations. METHODS: Forty-nine HBV isolates of Mexico obtained from sera of 15 hepatitis patients, 6 hemodialysis patients, 20 men seeking HIV testing, and 8 AIDS patients were analyzed. HBV isolates were amplified by PCR, and genotyped by line probe assay (INNO-LiPA HBV Genotyping; INNOGENETICS N V, Ghent, Belgium). HBV genotype confirmation was performed by DNA sequencing part of the sAg region. Precore and core promoter mutation characterization was performed by line probe assay (INNO-LiPA HBV PreCore; INNOGENETICS N V, Ghent, Belgium). RESULTS: Overall, HBV genotype H was found in 37 (75.5%) out of the 49 isolates studied. HBV genotypes G, A, and D were found in 5 (10.2%), 4 (8.2%), and 3 (6.1%) isolates, respectively. HBV genotype H was predominant in isolates from hemodialysis patients (100%), hepatitis patients (80%), and men seeking HIV testing (75%), and accounted for half of infections in AIDS patients (50%). Six (12.2%) out of the 49 HBV isolates showed both wild type and mutant populations at precore codon 28. These mixed wild type and precore mutant populations were observed in one HBV genotype A isolate and in all HBV genotype G isolates. A dual variant core promoter mutation was observed in 1 (2%) of the isolates, which was genotype H. CONCLUSION: HBV genotype H is highly predominant in HBV isolates of Mexico followed by genotypes G, A and D. A low frequency of precore and core promoter mutations is observed in HBV Mexican isolates.
AIM: To determine the genotypes in Mexican hepatitis B virus (HBV) isolates and characterize their precore and core promoter mutations. METHODS: Forty-nine HBV isolates of Mexico obtained from sera of 15 hepatitispatients, 6 hemodialysis patients, 20 men seeking HIV testing, and 8 AIDSpatients were analyzed. HBV isolates were amplified by PCR, and genotyped by line probe assay (INNO-LiPA HBV Genotyping; INNOGENETICS N V, Ghent, Belgium). HBV genotype confirmation was performed by DNA sequencing part of the sAg region. Precore and core promoter mutation characterization was performed by line probe assay (INNO-LiPA HBV PreCore; INNOGENETICS N V, Ghent, Belgium). RESULTS: Overall, HBV genotype H was found in 37 (75.5%) out of the 49 isolates studied. HBV genotypes G, A, and D were found in 5 (10.2%), 4 (8.2%), and 3 (6.1%) isolates, respectively. HBV genotype H was predominant in isolates from hemodialysis patients (100%), hepatitispatients (80%), and men seeking HIV testing (75%), and accounted for half of infections in AIDSpatients (50%). Six (12.2%) out of the 49 HBV isolates showed both wild type and mutant populations at precore codon 28. These mixed wild type and precore mutant populations were observed in one HBV genotype A isolate and in all HBV genotype G isolates. A dual variant core promoter mutation was observed in 1 (2%) of the isolates, which was genotype H. CONCLUSION:HBV genotype H is highly predominant in HBV isolates of Mexico followed by genotypes G, A and D. A low frequency of precore and core promoter mutations is observed in HBV Mexican isolates.
Authors: Yongzhong Wang; Guoping Zhou; Xiating Li; Zhiwu Zhou; Shengsheng Zhou; Lihua Ruan; Min Chen; Weiqun Deng Journal: Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi Date: 2002-12
Authors: L A Juárez-Figueroa; F J Uribe-Salas; C J Conde-Glez; M Hernández-Avila; P Hernández-Nevárez; P Uribe-Zúñiga; C del Río-Chiriboga Journal: Sex Transm Dis Date: 1997-04 Impact factor: 2.830
Authors: C M Lee; C H Chen; S N Lu; H D Tung; W J Chou; J H Wang; T M Chen; C H Hung; C C Huang; W J Chen Journal: Scand J Gastroenterol Date: 2003-01 Impact factor: 2.423
Authors: Francisco C A Mello; Oscar C Araujo; Barbara V Lago; Ana Rita C Motta-Castro; Marcia Terezinha B Moraes; Selma A Gomes; Gonzalo Bello; Natalia M Araujo Journal: Virol J Date: 2013-07-16 Impact factor: 4.099
Authors: Alexander A Martínez; Yamitzel Zaldívar; Griselda Arteaga; Zoila de Castillo; Alma Ortiz; Yaxelis Mendoza; Omar Castillero; Juan A Castillo; Juan Cristina; Juan M Pascale Journal: PLoS One Date: 2015-07-31 Impact factor: 3.240